Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

DR CHALLUT : revenue, balance sheet and financial ratios

DR CHALLUT is a French company founded 4 years ago, specialized in the sector Fonds de placement et entités financières similaires. Based in LE PORT (97420), this company of category PME shows in 2024 a net income negative of -2€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - DR CHALLUT (SIREN 905117552)
Indicator 2024 2023 2022
Revenue N/C N/C N/C
Net income -2 € -145 € -14 €
EBITDA N/C N/C -14 €
Net margin N/C N/C N/C

Revenue and income statement

In 2024, DR CHALLUT records a net loss of 2 €. This deficit will reduce equity on the balance sheet.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-2 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 118%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 46%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

118.138%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

45.842%

Solvency indicators evolution
DR CHALLUT

Sector positioning

Debt ratio
118.14 2024
2022
2023
2024
Q1: 0.01
Med: 13.69
Q3: 116.56
Average +50 pts over 3 years

In 2024, the debt ratio of DR CHALLUT (118.14) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
45.84% 2024
2022
2023
2024
Q1: 13.95%
Med: 55.8%
Q3: 90.35%
Average -31 pts over 3 years

In 2024, the financial autonomy of DR CHALLUT (45.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
0.0 years 2022
2022
Q1: -0.0 years
Med: 0.04 years
Q3: 3.93 years
Good

In 2022, the repayment capacity of DR CHALLUT (0.00) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Positioning of DR CHALLUT in its sector

Comparison with sector Fonds de placement et entités financières similaires

Similar companies (Fonds de placement et entités financières similaires)

Compare DR CHALLUT with other companies in the same sector:

Frequently asked questions about DR CHALLUT

What is the revenue of DR CHALLUT ?

The revenue of DR CHALLUT is not publicly disclosed (confidential accounts filed with INPI).

Is DR CHALLUT profitable?

DR CHALLUT recorded a net loss in 2024.

Where is the headquarters of DR CHALLUT ?

The headquarters of DR CHALLUT is located in LE PORT (97420), in the department La Reunion.

Where to find the tax return of DR CHALLUT ?

The tax return of DR CHALLUT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does DR CHALLUT operate?

DR CHALLUT operates in the sector Fonds de placement et entités financières similaires (NAF code 64.30Z). See the 'Sector positioning' section above to compare the company with its competitors.